Reduction of Immunosuppression as Initial Therapy for Posttransplantation Lymphoproliferative Disorder★Ran Reshef, Daniel Tsai, Karen Krok et al.|American Journal of Transplantation|2011Cited by 218
The Impact of EBV Status on Characteristics and Outcomes of Posttransplantation Lymphoproliferative DisorderMarlise R. Luskin, Ran Reshef, Daniel S. Heil et al.|American Journal of Transplantation|2015Cited by 174
Association of HLA Polymorphisms with Post-transplant Lymphoproliferative Disorder in Solid-Organ Transplant RecipientsRan Reshef, De.E. Tsai, Daniel F. Heitjan et al.|American Journal of Transplantation|2011Cited by 56